Stage I Lung Cancer AJCC v7

general

Stage I includes: IA: (T1a, N0, M0); (T1b, N0, M0) and IB: (T2a, N0, M0). T1a: Lung cancer with a tumor size of 2 cm or less n greatest dimension, surrounded by lung or visceral pleura and without bronchoscopic evidence of invasion more proximal than the lobar bronchus (i.e., not in the main bronchus). The uncommon superficial tumor of any size with its invasive component limited to the bronchial wall, which may extend proximal to the main bronchus, is also classified as T1a. T1b: Lung cancer

32

Centers

32

Active Trials

Cancer Funding

Specific Cancer Types(1)

NameCenters
Stage IB Lung Cancer AJCC v7

Top Centers for Stage I Lung Cancer AJCC v7(32)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
Active Research Program
51.6
2
NCI Comprehensive
Active Research Program
51.6
3
NCI Comprehensive
Active Research Program
51.6
4
NCI Comprehensive
Active Research Program
51.6
551.6
6
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
Active Research Program
51.6
7
NCI Comprehensive
Active Research Program
51.6
8
NCI Comprehensive
Active Research Program
51.6
9
NCI Comprehensive
Active Research Program
51.6
10
NCI Comprehensive
Active Research Program
51.6
11
NCI Clinical
Active Research Program
51.6
12
NCI Comprehensive
Active Research Program
51.6
13
Active Research Program
51.6
14
NCI Comprehensive
Active Research Program
51.6
15
NCI Clinical
Active Research Program
51.6
16
NCI Comprehensive
Active Research Program
51.6
17
Active Research Program
51.6
18
NCI Comprehensive
Active Research Program
51.6
19
Active Research Program
51.6
2051.6
21
Active Research Program
51.6
22
Active Research Program
51.6
23
Active Research Program
51.6
24
Active Research Program
51.6
25
Active Research Program
51.6
26
Active Research Program
51.6
27
Active Research Program
51.6
28
Active Research Program
51.6
29
Active Research Program
51.6
30
Active Research Program
51.6
31
Active Research Program
51.6
32
Active Research Program
51.6

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →